[{"address1": "2223 Avenida de la Playa", "address2": "Suite 208", "city": "LA Jolla", "state": "CA", "zip": "92037", "country": "United States", "phone": "619 400 1170", "website": "https://www.gribio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase II clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company's portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 for the treatment of primary sclerosing cholangitis, and GRI-0729, which are in pre-clinical development. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Dr. W. Marc Hertz Ph.D.", "age": 53, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 842014, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Albert  Agro Ph.d.", "age": 59, "title": "Co-Founder & Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 461099, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leanne M. Kelly", "age": 47, "title": "CFO & Corporate Secretary", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 550930, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Vipin  Kumar Chaturvedi Ph.D.", "age": 64, "title": "Co-Founder & Chief Scientific Officer", "yearBorn": 1960, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Cristina Gil White", "title": "Interim Chief Executive Officer of Global Reporting Initiative", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.93, "open": 5.99, "dayLow": 5.99, "dayHigh": 5.99, "regularMarketPreviousClose": 5.93, "regularMarketOpen": 5.99, "regularMarketDayLow": 5.99, "regularMarketDayHigh": 5.99, "payoutRatio": 0.0, "trailingPE": 0.0045447303, "forwardPE": -2.2775664, "volume": 1277, "regularMarketVolume": 1277, "averageVolume": 11290, "averageVolume10days": 6360, "averageDailyVolume10Day": 6360, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 3147697, "fiftyTwoWeekLow": 5.134, "fiftyTwoWeekHigh": 186.966, "fiftyDayAverage": 9.71274, "twoHundredDayAverage": 17.1501, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -1467302, "profitMargins": 0.0, "floatShares": 524888, "sharesOutstanding": 525492, "sharesShort": 27406, "sharesShortPriorMonth": 20506, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.052199997, "heldPercentInsiders": 0.00115, "heldPercentInstitutions": 0.02506, "shortRatio": 2.01, "shortPercentOfFloat": 0.052199997, "impliedSharesOutstanding": 525492, "bookValue": 12.387, "priceToBook": 0.48357147, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -8263000, "trailingEps": 1318.01, "forwardEps": -2.63, "lastSplitFactor": "1:17", "lastSplitDate": 1740355200, "enterpriseToEbitda": 0.177, "52WeekChange": -0.96410054, "SandP52WeekChange": 0.09506309, "quoteType": "EQUITY", "currentPrice": 5.99, "targetHighPrice": 221.0001, "targetLowPrice": 170.00009, "targetMeanPrice": 195.5001, "targetMedianPrice": 195.5001, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 4746000, "totalCashPerShare": 9.032, "ebitda": -8303000, "totalDebt": 131000, "quickRatio": 2.767, "currentRatio": 3.104, "debtToEquity": 3.579, "returnOnAssets": -1.0527999, "returnOnEquity": -2.8072, "freeCashflow": -5205875, "operatingCashflow": -12172000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "GRI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "fiftyTwoWeekLowChange": 0.85599995, "fiftyTwoWeekLowChangePercent": 0.1667316, "fiftyTwoWeekRange": "5.134 - 186.966", "fiftyTwoWeekHighChange": -180.976, "fiftyTwoWeekHighChangePercent": -0.9679621, "fiftyTwoWeekChangePercent": -96.41006, "earningsTimestamp": 1741982400, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747398600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 1318.01, "epsForward": -2.63, "epsCurrentYear": -15.72501, "priceEpsCurrentYear": -0.38092184, "fiftyDayAverageChange": -3.7227402, "fiftyDayAverageChangePercent": -0.38328424, "twoHundredDayAverageChange": -11.160101, "twoHundredDayAverageChangePercent": -0.6507309, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Vallon Pharmaceuticals, Inc.", "nameChangeDate": "2025-03-14", "cryptoTradeable": false, "shortName": "GRI Bio, Inc.", "longName": "GRI Bio, Inc.", "regularMarketChangePercent": 1.0118035, "regularMarketPrice": 5.99, "exchange": "NCM", "messageBoardId": "finmb_136941170", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612967400000, "regularMarketChange": 0.059999943, "regularMarketDayRange": "5.99 - 5.99", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 11290, "marketState": "CLOSED", "corporateActions": [], "regularMarketTime": 1741982400, "displayName": "GRI Bio", "trailingPegRatio": null, "__fetch_time": "2025-03-15"}]